Amanda M Brock
University of Pennsylvania, USA
Title: The Role of Palliative Care in Phase 1 Oncology Clinical Trial Participants
Biography
Biography: Amanda M Brock
Abstract
Integration of Palliative Care into oncology care has been a challenge since the inception of palliative care programs. Phase 1 oncology clinical trial participants are considered a distinctly vulnerable population. They are at high risk for lack of follow through by the healthcare system after being withdrawn from the clinical trial. In addition, they are at risk for therapeutic misconception and major challenges associated with dual enrollment on the trial and hospice programs. Patients with dual enrollment in palliative care and phase 1 trials could live longer lives, remain on trials for longer, have higher rates of advance directive completion, and may be more likely to die comfortably at home. Palliative Care consultation upon Phase 1 trial enrollment can could improve the quality of the research being conducted as well as improve Quality of Life for trial participants.